pyrazinamide has been researched along with Central Nervous System Infection in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, AB | 1 |
| Grimwood, K | 1 |
| Harvey, AS | 1 |
| Rosenfeld, JV | 1 |
| Olinsky, A | 1 |
1 other study available for pyrazinamide and Central Nervous System Infection
| Article | Year |
|---|---|
Central nervous system tuberculosis after resolution of miliary tuberculosis.
Topics: Antitubercular Agents; Central Nervous System Infections; Dexamethasone; Drug Therapy, Combination; | 1998 |